An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

NCT00210652 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Epilepsies, Partial

Interventions

DRUG: RWJ 333369:

Sponsor

SK Life Science, Inc.